Gabapentin to Reduce Alcohol and Improve Viral Load Suppression
Clinical trial NCT05443555 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05443555
- Sponsor
- Boston Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2026-10-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.